HBA2 and thalassemia: With the introduction of NGS, retrospective analysis of these samples using the Devyser Thalassemia panel confirmed the MLPA-detected deletions, validating the loss of critical regions including HBA1, HBA2, and HS-40, reinforcing their classification as full α0 deletions.